Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, CervoMed Inc’s stock clocked out at $2.18, down -5.63% from its previous closing price of $2.31. In other words, the price has decreased by -$5.63 from its previous closing price. On the day, 0.14 million shares were traded. CRVO stock price reached its highest trading level at $2.3 during the session, while it also had its lowest trading level at $2.16.
Ratios:
To gain a deeper understanding of CRVO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.04 and its Current Ratio is at 15.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 27 ’24 when ELDER WILLIAM ROBERT bought 1,000 shares for $18.16 per share. The transaction valued at 18,160 led to the insider holds 1,267 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRVO now has a Market Capitalization of 17993154 and an Enterprise Value of -28663748. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.79 while its Price-to-Book (P/B) ratio in mrq is 0.39. Its current Enterprise Value per Revenue stands at -2.847.
Stock Price History:
The Beta on a monthly basis for CRVO is 1.77, which has changed by -0.7680851 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, CRVO has reached a high of $26.38, while it has fallen to a 52-week low of $1.80. The 50-Day Moving Average of the stock is -71.22%, while the 200-Day Moving Average is calculated to be -85.88%.
Shares Statistics:
It appears that CRVO traded 413.42K shares on average per day over the past three months and 278280 shares per day over the past ten days. A total of 8.25M shares are outstanding, with a floating share count of 5.35M. Insiders hold about 35.20% of the company’s shares, while institutions hold 42.48% stake in the company. Shares short for CRVO as of 1734048000 were 2590557 with a Short Ratio of 6.27, compared to 1731628800 on 1669253. Therefore, it implies a Short% of Shares Outstanding of 2590557 and a Short% of Float of 48.430002.
Earnings Estimates
The current rating of CervoMed Inc (CRVO) reflects the combined expertise of 7.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.58, with high estimates of -$0.52 and low estimates of -$0.67.
Analysts are recommending an EPS of between -$1.34 and -$1.73 for the fiscal current year, implying an average EPS of -$1.51. EPS for the following year is -$1.86, with 7.0 analysts recommending between -$0.94 and -$3.46.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $1.82M. It ranges from a high estimate of $3.4M to a low estimate of $1M. As of the current estimate, CervoMed Inc’s year-ago sales were $2.49MFor the next quarter, 7 analysts are estimating revenue of $1.32M. There is a high estimate of $1.55M for the next quarter, whereas the lowest estimate is $1.1M.
A total of 8 analysts have provided revenue estimates for CRVO’s current fiscal year. The highest revenue estimate was $11M, while the lowest revenue estimate was $8.1M, resulting in an average revenue estimate of $9.09M. In the same quarter a year ago, actual revenue was $7.14MBased on 8 analysts’ estimates, the company’s revenue will be $5.55M in the next fiscal year. The high estimate is $11.9M and the low estimate is $2M.
